As of Feb 16
| +0.13 / +4.23%|
The 5 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +56.25% increase from the last price of 3.20.
The current consensus among 5 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.